Matsiras, D.; Ventoulis, I.; Verras, C.; Bistola, V.; Bezati, S.; Fyntanidou, B.; Polyzogopoulou, E.; Parissis, J.T.
Proenkephalin 119–159 in Heart Failure: From Pathophysiology to Clinical Implications. J. Clin. Med. 2025, 14, 2657.
https://doi.org/10.3390/jcm14082657
AMA Style
Matsiras D, Ventoulis I, Verras C, Bistola V, Bezati S, Fyntanidou B, Polyzogopoulou E, Parissis JT.
Proenkephalin 119–159 in Heart Failure: From Pathophysiology to Clinical Implications. Journal of Clinical Medicine. 2025; 14(8):2657.
https://doi.org/10.3390/jcm14082657
Chicago/Turabian Style
Matsiras, Dionysis, Ioannis Ventoulis, Christos Verras, Vasiliki Bistola, Sofia Bezati, Barbara Fyntanidou, Effie Polyzogopoulou, and John T. Parissis.
2025. "Proenkephalin 119–159 in Heart Failure: From Pathophysiology to Clinical Implications" Journal of Clinical Medicine 14, no. 8: 2657.
https://doi.org/10.3390/jcm14082657
APA Style
Matsiras, D., Ventoulis, I., Verras, C., Bistola, V., Bezati, S., Fyntanidou, B., Polyzogopoulou, E., & Parissis, J. T.
(2025). Proenkephalin 119–159 in Heart Failure: From Pathophysiology to Clinical Implications. Journal of Clinical Medicine, 14(8), 2657.
https://doi.org/10.3390/jcm14082657
